Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-34877
Roth, P; Junker, M; Tritschler, I; Mittelbronn, M; Dombrowski, Y; Breit, S N; Tabatabai, G; Wick, W; Weller, M; Wischhusen, J (2010). GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clinical Cancer Research, 16(5):3851-3859.
PDF - Registered users only
PURPOSE: Growth and differentiation factor (GDF)-15 is a member of the transforming growth factor (TGF)-beta family. GDF-15 is necessary for the maintenance of pregnancy but has also been linked to other physiological and pathological conditions. EXPERIMENTAL DESIGN: The expression of GDF-15 in glioma cell lines was assessed by qRT-PCR and immunoblot. GDF-15 levels in situ and in peripheral blood of glioma patients were examined by immunohistochemistry and ELISA, respectively. Effects of shRNA-mediated GDF-15 inhibition on proliferation and immunogenicity of SMA-560 glioma cells were investigated by [methyl-3H]thymidine incorporation and immune-mediated target cell lysis. The impact of GDF-15 on glioma growth in vivo was assessed in syngeneic mice.RESULTS: GDF-15 is expressed by gliomas of different WHO grades as assessed by immunohistochemistry. The high expression of GDF-15 in tumor tissue translates into elevated GDF-15 serum levels in glioblastoma patients compared to healthy controls. GDF-15 mRNA and protein are also detectable in human and mouse glioma cells in vitro. Silencing of GDF-15 by RNA interference reduces the proliferation of malignant glioma cells. Immunologically, the depletion of glioma-derived GDF-15 enhances the susceptibility of mouse glioma cells towards syngeneic NK cells and splenocytes. This results into a reduced in vivo tumorigenicity and increased T cell infiltration of GDF-15-deficient glioma cells in syngeneic mice. CONCLUSIONS: While previous studies focussing on ectopic overexpression of GDF-15 have proposed unclear or anti-tumorigenic effects of GDF-15 in glioma cells, we here show that GDF-15 at endogenous levels contributes to proliferation and immune escape of malignant gliomas in an immunocompetent host.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology|
|DDC:||610 Medicine & health|
|Deposited On:||15 Jul 2010 14:38|
|Last Modified:||02 Apr 2014 14:23|
|Publisher:||American Association for Cancer Research|
|Free access at:||Publisher DOI. An embargo period may apply.|
|Citations:||Web of Science®. Times Cited: 20|
Scopus®. Citation Count: 21
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page